Postsynaptic movement disorders: clinical phenotypes, genotypes, and disease mechanisms.

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Movement disorders present complex phenotypes, often lacking diagnostic biomarkers, complicating diagnosis.
• Next-generation sequencing has advanced the identification of genetic causes for movement disorders.
• Disruptions in postsynaptic dopaminergic signaling in the striatum are implicated in novel hyperkinetic disorders.

Purpose of the Study:

• To review the clinical features, genetic underpinnings, and pathogenic mechanisms of newly identified genetic postsynaptic movement disorders.
• To highlight the role of the cAMP pathway in these conditions.

Main Methods:

• Literature review of studies on genetic movement disorders.
• Analysis of clinical presentations and genetic findings.
• Examination of disease mechanisms, focusing on postsynaptic signaling pathways.

Main Results:

• Several hyperkinetic movement disorders are linked to genetic defects affecting the cAMP pathway.
• These genes are crucial for postsynaptic signaling in striatal medium spiny neurons.
• Dopaminergic signaling deficits are a common pathogenic theme.

Conclusions:

• Genetic postsynaptic movement disorders represent a significant diagnostic challenge.
• Understanding the cAMP pathway's role is key to diagnosing and potentially treating these disorders.
• Advances in genetic sequencing are crucial for unraveling the etiology of movement disorders.